Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Jung

Showing results (131-140 of 253) with videos related to

Pageof 26
Sort By:
Molecular Biosystems|December 7, 2010
From cosubstrate similarity to inhibitor diversity--inhibitors of ADP-ribosyltransferases from kinase inhibitor screeningBenjamin Maurer, Ulf Mathias, Panagiotis Papatheodorou, et al.
Journal of Medicinal Chemistry|December 8, 2006
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibitionJohannes Trapp, Anne Jochum, Rene Meier, et al.
Future Medicinal Chemistry|May 22, 2015
Schistosome sirtuins as drug targetsJulien Lancelot, Alejandro Cabezas-Cruz, Stéphanie Caby, et al.
European Journal of Medicinal Chemistry|August 29, 2020
Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigationsCarina Glas, Johannes C B Dietschreit, Nathalie Wössner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5Benjamin Maurer, Tobias Rumpf, Michael Scharfe, et al.
European Journal of Medicinal Chemistry|February 3, 2023
A novel pan-selective bromodomain inhibitor for epigenetic drug designRobin Warstat, Mehrosh Pervaiz, Pierre Regenass, et al.
Journal of Medicinal Chemistry|April 6, 2017
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)Matthias Schiedel, Daniel Herp, Sören Hammelmann, et al.
Molecular Cancer Research : MCR|July 23, 2008
Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6Gary K Scott, Corina Marx, Crystal E Berger, et al.
Biochimica Et Biophysica Acta. General Subjects|January 7, 2019
Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imineMarius Muth, Niklas Jänsch, Aleksandra Kopranovic, et al.
Chemmedchem|November 6, 2008
Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testingUrszula Uciechowska, Jörg Schemies, Robert C Neugebauer, et al.
Pageof 26

Showing results (131-140 of 253) with videos related to

Sort By:
Pageof 26
Molecular Biosystems|December 7, 2010
From cosubstrate similarity to inhibitor diversity--inhibitors of ADP-ribosyltransferases from kinase inhibitor screeningBenjamin Maurer, Ulf Mathias, Panagiotis Papatheodorou, et al.
Journal of Medicinal Chemistry|December 8, 2006
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibitionJohannes Trapp, Anne Jochum, Rene Meier, et al.
Future Medicinal Chemistry|May 22, 2015
Schistosome sirtuins as drug targetsJulien Lancelot, Alejandro Cabezas-Cruz, Stéphanie Caby, et al.
European Journal of Medicinal Chemistry|August 29, 2020
Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigationsCarina Glas, Johannes C B Dietschreit, Nathalie Wössner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5Benjamin Maurer, Tobias Rumpf, Michael Scharfe, et al.
European Journal of Medicinal Chemistry|February 3, 2023
A novel pan-selective bromodomain inhibitor for epigenetic drug designRobin Warstat, Mehrosh Pervaiz, Pierre Regenass, et al.
Journal of Medicinal Chemistry|April 6, 2017
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)Matthias Schiedel, Daniel Herp, Sören Hammelmann, et al.
Molecular Cancer Research : MCR|July 23, 2008
Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6Gary K Scott, Corina Marx, Crystal E Berger, et al.
Biochimica Et Biophysica Acta. General Subjects|January 7, 2019
Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imineMarius Muth, Niklas Jänsch, Aleksandra Kopranovic, et al.
Chemmedchem|November 6, 2008
Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testingUrszula Uciechowska, Jörg Schemies, Robert C Neugebauer, et al.
Pageof 26